You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 635 A phase 1, first in human (FIH) study of autologous macrophages engineered to express an anti-HER2 chimeric antigen receptor (CAR) in participants (pts) with HER2 overexpressing solid tumors

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
635 A phase 1, first in human (FIH) study of autologous macrophages engineered to express an anti-HER2 chimeric antigen receptor (CAR) in participants (pts) with HER2 overexpressing solid tumors

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023242024
Dec 20238806
Jan 20249508
Feb 20245608
Mar 20244403
Apr 20246206
May 20242200
Jun 20244403
Jul 20242402
Aug 20242201
Sep 20242807
Oct 20243808
Nov 20245807
Dec 202458012
Jan 20253309
Feb 20256014
Mar 20250019
Apr 2025001
May 2025004
Jun 2025003
Total9200145